<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Amendment No.:1*
Name of Issuer: Biogen, Inc.
Title of Class of Securities: Common Stock
CUSIP Number: 09059710-5
Check the following line if a fee is being paid with this
statement __. (A fee is not required only if the filing person:
(1) has a previous statement on file reporting beneficial
ownership of more than five percent of the class of securities
described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of
such class.)(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No.: 09059710-5
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Janus Capital Corporation
EIN #84-0765359
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
a. ___
b. _X_
3. SEC USE ONLY
4. CITIZENSHIP OF PLACE OF ORGANIZATION
Colorado
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
5. SOLE VOTING POWER
-0-
6. SHARED VOTING POWER
1,469,300 **
7. SOLE DISPOSITIVE POWER
-0-
8. SHARED DISPOSITIVE POWER
1,469,300 **
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,469,300 **
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES
N/A
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.4% **
12. TYPE OF REPORTING PERSON
IA, CO
** See Item 4 of this filing
<PAGE>
CUSIP No.: 09059710-5
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Thomas H. Bailey
SS ####-##-####
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
a. ___
b. _X_
3. SEC USE ONLY
4. CITIZENSHIP OF PLACE OF ORGANIZATION
USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:
5. SOLE VOTING POWER
-0-
6. SHARED VOTING POWER
1,469,300 **
7. SOLE DISPOSITIVE POWER
-0-
8. SHARED DISPOSITIVE POWER
1,469,300 **
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,469,300 **
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES
N/A
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.4% **
12. TYPE OF REPORTING PERSON
IN
** See Item 4 of this filing
<PAGE>
Item 1.
(a). Name of Issuer: Biogen, Inc. ("Biogen")
(b). Address of Issuer's Principal Executive Offices:
14 Cambridge Center
Cambridge , MA 02142
Item 2.
(a).-(c). Name, Principal Business Address, and Citizenship
of Persons Filing:
(1) Janus Capital Corporation ("Janus Capital")
100 Fillmore Street, Suite 300
Denver, Colorado 80206-4923
Citizenship: Colorado
(2) Thomas H. Bailey ("Mr. Bailey")
100 Fillmore Street, Suite 300
Denver, Colorado 80206-4923
Citizenship: USA
(d). Title of Class of Securities: Common Stock
(e). CUSIP Number: 09059710-5
Item 3.
Janus Capital is an Investment Adviser registered under
Section 203 of the Investment Advisers Act of 1940.
Item 4. Ownership
The information in items 1 and 5 through 11 on the
cover pages (pp. 2 & 3) on Schedule 13G is hereby
incorporated by reference.
<PAGE>
Janus Capital is a registered investment adviser which
furnishes investment advice to several investment
companies registered under Section 8 of the Investment
Company Act of 1940 and individual and institutional
clients (collectively referred to herein as "Managed
Portfolios"). As a result of its role as investment
adviser or sub-adviser to the Managed Portfolios,
Janus Capital may be deemed to be the beneficial owner
of the shares of Biogen Common Stock held by such
Managed Portfolios. However, Janus Capital does not
have the right to receive any dividends from, or the
proceeds from the sale of, the securities held in the
Managed Portfolios and disclaims any ownership
associated with such rights.
Mr. Bailey owns approximately 17.6% of Janus Capital.
In addition to being a stockholder of Janus Capital,
Mr. Bailey serves as President and Chairman of the
Board of Janus Capital and is filing this joint
statement with Janus Capital as a result of such stock
ownership and positions which may be deemed to enable
him to exercise control over Janus Capital. Mr.
Bailey does not own of record any shares of Biogen
Common Stock and he has not engaged in any transaction
in Biogen Common Stock. However, as a result of his
position, Mr. Bailey may be deemed to have the power
to exercise or to direct the exercise of such voting
and/or dispositive power that Janus Capital may have
with respect to Biogen Common Stock held by the
Managed Portfolios. All shares reported herein have
been acquired by the Managed Portfolios, and Mr.
Bailey specifically disclaims beneficial ownership
over any shares of Biogen Common Stock that he or
Janus Capital may be deemed to beneficially own.
Furthermore, Mr. Bailey does not have the right to
receive any dividends from, or the proceeds from the
sale of, the securities held in the Managed Portfolios
and disclaims any ownership associated with such
rights.
<PAGE>
Item 5. Ownership of Five Percent or Less of a Class
This statement is being filed to report the fact that
as of the date hereof the reporting persons have
ceased to be the beneficial owners of more than five
percent of the class of securities.
Janus Capital's Managed Portfolios have the right to
receive all dividends from, and the proceeds from the
sale of, the securities held in their respective
accounts.
Item 6. Ownership of More than Five Percent on Behalf of
Another Person
N/A
Item 7. Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on by the
Parent Holding Company
N/A
Item 8. Identification and Classification of Members of the
Group
N/A
Item 9. Notice of Dissolution of Group
N/A
<PAGE>
Item 10. Certification
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to above
were acquired in the ordinary course of business and
were not acquired for the purpose of and do not have
the effect of changing or influencing the control of
the issuer of such securities and were not acquired in
connection with or as a participant in any transaction
having such purposes or effect.
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.
JANUS CAPITAL CORPORATION
By /s/ David C. Tucker 11/09/94
David C. Tucker, Vice President Date
THOMAS H. BAILEY
By /s/ David C. Tucker 11/09/94
David C. Tucker Date
Under Power of Attorney dated 2/10/94
On File with Schedule 13G for
Navigators Group, Inc. 2/11/94
<PAGE>
EXHIBIT A
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(f) under the Securities
Exchange Act of 1934, the persons named below agree to the joint
filing on behalf of each of them of a Statement on Schedule 13G
(including amendments thereto) with respect to the Common Stock
of Biogen, Inc. and further agree that this Joint Filing
Agreement be included as an Exhibit to such joint filings. In
evidence thereof, the undersigned hereby execute this Agreement
as of the 9th day of November , 1994.
JANUS CAPITAL CORPORATION
By /s/ David C. Tucker
David C. Tucker, Vice President
THOMAS H. BAILEY
By /s/ David C. Tucker
David C. Tucker
Under Power of Attorney dated 2/10/94
On File with Schedule 13G for
Navigators Group, Inc. 2/11/94
